Stavudine made available under parallel track policy.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000998:Antiviral Agents / Q000627:therapeutic use; D015224:Dideoxynucleosides / Q000627:therapeutic use; D017277:Drug Approval; D006291:Health Policy; D006801:Humans; D018119:Stavudine; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D015224:Dideoxynucleosides; D018119:Stavudine